THE TYSABRI® (natalizumab)

A commitment to patient safety

Patient tracking from the TOUCH® Prescribing Program
helps keep you informed about your patients taking

  • Because of the risk of PML, TYSABRI is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the TOUCH Prescribing Program
  • The TOUCH Prescribing Program has been designed to facilitate appropriate
    use of TYSABRI
  • TOUCH On-Line is a web-based tool designed to:
    • Provide real-time access to data for patients taking TYSABRI
    • Maintain compliance with the TOUCH Prescribing Program
    • Reduce administrative burden/paperwork for prescribers and infusion sites
    • Streamline communication to/from prescribers and infusion sites
  • TOUCH On-Line is accessed with a secure username and password

Enrollment requirements for the TOUCH Prescribing Program

  • Under the TOUCH Prescribing Program, only prescribers, pharmacies, and infusion sites enrolled in the program are able to prescribe, distribute, or infuse TYSABRI. Only patients who are enrolled in and meet all the conditions of the program may receive TYSABRI
  • To enroll in the TOUCH Prescribing Program, prescribers and patients are required to understand the risks of treatment with TYSABRI, including PML and other opportunistic infections, and to review, complete, and sign the Patient Enrollment Form, the Start Form, and the Prescriber Enrollment Form (only required for new TYSABRI prescribers)

How to get started with the TOUCH Prescribing Program

If you are already enrolled in the TOUCH®
Prescribing Program:

If you are not enrolled:

Call the TOUCH Hotline at 1-800-456-2255
(Available Monday through Friday 8:30 AM to 8:00 PM ET)
OR Fax 1-800-840-1278

TOUCH On-Line is a valuable resource for your office

Real-Time TOUCH Data

With patient consent via our new DocuSign tool, you can now have convenient access to your patient's JCV status/index history with TOUCH On-Line

Automated Reminders

Real-time TOUCH data are at your fingertips, providing personalized patient information such as JCV status and infusion schedule

Streamlined Process

Online portal that allows you to enroll patients, collect consent, and download resources to educate your patients and office staff


Once patients are registered in the TOUCH Prescribing Program, they are automatically enrolled to participate in the optional TYSABRI Ongoing Support Program. Biogen also provides a variety of financial and insurance assistance options to help your patients get started on TYSABRI.

Prescribers must:

  • Review the TOUCH Prescribing Program prescriber educational materials, including the full Prescribing Information
  • Educate patients on the benefits and risks of treatment with TYSABRI, ensure that patients receive the Medication Guide, and encourage them to ask questions
  • Determine every 6 months whether their patient should continue on treatment and submit the TYSABRI Patient Status Report and Reauthorization Questionnaire
  • Report cases of PML, hospitalizations due to opportunistic infections, and deaths to Biogen at 1-800-456-2255 as soon as possible